Provided by Tiger Trade Technology Pte. Ltd.

Arrowhead Pharmaceuticals

60.77
+4.508.00%
Pre-market: 55.90-4.8700-8.01%08:53 EDT
Volume:3.39M
Turnover:206.34M
Market Cap:8.51B
PE:41.20
High:62.81
Open:57.29
Low:57.29
Close:56.27
52wk High:76.76
52wk Low:9.57
Shares:140.01M
Float Shares:120.00M
Volume Ratio:1.15
T/O Rate:2.82%
Dividend:- -
Dividend Rate:- -
EPS(TTM):1.48
EPS(LYR):-0.0122
ROE:75.50%
ROA:14.35%
PB:14.97
PE(LYR):-4,984.01

Loading ...

Sep 08, 2020

Major Issues Report

8-K - Current report
Aug 05, 2020

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 05, 2020

Major Issues Report

8-K - Current report
May 22, 2020

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
May 07, 2020

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
May 07, 2020

Major Issues Report

8-K - Current report
May 01, 2020

Major Issues Report

8-K - Current report
Mar 19, 2020

Major Issues Report

Current report, items 1.01, 2.03, and 5.07
Feb 14, 2020

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Feb 13, 2020

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Feb 12, 2020

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Feb 05, 2020

Quarterly Report

Quarterly report [Sections 13 or 15(d)]
Feb 05, 2020

Major Issues Report

Current report, items 2.02 and 9.01
Feb 04, 2020

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Feb 04, 2020

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Dec 18, 2019

Major Issues Report

Current report, item 5.02
Dec 06, 2019

Major Issues Report

Current report, items 1.01 and 9.01
Nov 25, 2019

Annual Report

Annual report [Section 13 and 15(d), not S-K Item 405]
Nov 25, 2019

Major Issues Report

Current report, items 2.02 and 9.01
Nov 21, 2019

Major Issues Report

Current report, item 5.02